Global Interventional Cardiology Market, 2018-2027 - Evolving Competitive Landscape of Cardiac Interventions Market

News provided by

Oct 17, 2018, 09:00 ET

DUBLIN, Oct. 17, 2018 /PRNewswire/ --

The "Global Interventional Cardiology Market: Focus on Devices (Conventional and Advanced), End Users, and Regions - Analysis and Forecast, 2018-2027" report has been added to ResearchAndMarkets.com's offering.

The global interventional cardiology market was estimated at $14.69 billion in 2017 and is anticipated to reach $24.96 billion by 2027.

Rising economic burden of chronic diseases is one of the prime concerns that the healthcare and biomedical device industries are currently facing. The high prevalence of chronic diseases such as as cancer, diabetes, cardiovascular diseases, and respiratory diseases, among others, poses one of the significant challenges across the globe.

Furthermore, change in eating habits, increased stress, smoking, alcohol consumption, and disturbed sleeping patterns are some of the key factors contributing to the deteriorating health condition in individuals and a rise in lifestyle disorders. It has been estimated that chronic diseases constitute approximately 43% of the global economic burden for diseases and accounts for 60% of the deaths worldwide.

It further holds approximately 65% of the annual healthcare cost of any country and comprises one-third of the global population at present. By 2020, the global spending on diseases such as cardiovascular diseases, cancer, and respiratory diseases is expected to reach $4 trillion. Moreover, growing geriatric population has resulted in increased prevalence of lifestyle disease that has led to an upsurge in the demand for advanced medical diagnosis and treatment.

Cardiovascular diseases (CVDs) represent the leading cause of death globally. According to the World Health Organization (WHO), CVD was estimated to claim 17.3 million lives, a number which is anticipated to grow to 23.6 million by 2030. Of these, coronary artery disease and stroke resulted in approximately 7.4 million deaths and 6.7 million deaths respectively. Interventional cardiology deals with the treatment of structural heart diseases specially employing the use of interventional catheters.

It involves the treatment of coronary artery disease, heart valve disease, and peripheral vascular disease, among others. With increase in the prevalence of cardiac diseases, advanced interventional cardiology devices are gradually becoming an integral part of the medical device industry.

The purpose of the study is to gain a holistic view of the advanced cardiac intervention market in terms of various factors influencing it such as recent trends and technological advancements of the market. The scope of this report is centered upon conducting a detailed study of the devices allied with the cardiac interventional devices market, which includes both conventional devices and imaging modalities. The global advanced cardiac intervention market is segmented into three different parts: devices, end users, and geography. The global market value was estimated using these three different approaches and was validated with one another. These segments are further segmented into several sub-segments to ease the market estimation.

With the rise in the demand for advanced medical devices to treat cardiovascular diseases, increasing geriatric population with higher life expectancy, and new product launches by several conglomerate companies, the cardiac intervention market is expected to witness moderate growth. The emergence of advanced imaging modalities such as IntraVenous UltraSound (IVUS), Optical Coherent Tomography (OCT), and Fractional Flow Reserve (FFR) has led to the growth of the market.

The global interventional cardiology is segmented by the geographical regions into North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World (RoW). North America is the leading contributor to the global interventional cardiology market. However, the Asia-Pacific is expected to grow at a CAGR of 7.12% in the forecast period 2018-2027. The global interventional cardiology market for advanced devices is majorly dominated by the U.S. and the European players.

Key Topics Covered:

Executive Summary
1 Market Overview
1.1 Types of Interventional Cardiology Procedures
1.2 Devices Used in Interventional Cardiology

2 Market Dynamics
2.1 Overview
2.2 Market Drivers
2.2.1 Rising Geriatric Population Due to Higher Life Expectancy
2.2.2 Increasing Clinical Evidence of Effectiveness of Advanced Interventional Cardiac Devices
2.2.3 Technological Advancements in Interventional Cardiac Devices
2.2.4 Growing Healthcare Budgetary Allocation in Emerging Economies
2.2.5 Increasing Awareness about Minimally Invasive Surgical Procedure among Patients
2.3 Market Restraints
2.3.1 Stringent Regulatory Requirements for Product Approval and Insufficient Reimbursement Policies
2.3.2 Complications and Risks Associated with the Use of Interventional Cardiac Devices
2.3.3 High Cost of Interventional Cardiology Procedures
2.4 Market Opportunities
2.4.1 Growing Awareness about Advanced Interventional Cardiac Devices
2.4.2 Global Shift toward Value-based Care (VBC)
2.4.3 Increasing Adoption of Innovative Treatment Technologies
2.4.4 Evolving Competitive Landscape of Cardiac Interventions Market

3 Industry Insights
3.1 Definition of Medical Devices
3.2 Framework for Medical Device Regulations
3.2.1 Medical Devices Reporting (MDR)
3.2.2 China Food and Drug Administration (CFDA) Guidelines for Medical Devices
3.2.3 Recommendations for IVUS, FFR, and OCT by Various Cardiology Societies
3.3 Patent Landscape

4 Competitive Landscape
4.1 Key Developmental Strategies
4.1.1 Product Approval
4.1.2 Clinical Study
4.1.3 Product Launch
4.1.4 Acquisitions
4.1.5 Partnership, Agreement, Joint Venture, and Collaboration
4.1.6 Business Expansion
4.1.7 Awards and Recognition
4.1.8 Others
4.2 Market Share Analysis
4.2.1 Market Share for Interventional Cardiology Market for Conventional Devices
4.2.2 Global Optical Coherent Tomography (OCT) Market Share
4.2.3 Global IVUS Market Share

5 Global Interventional Cardiology Market (by Devices)
5.1 Global Interventional Cardiology Market (by Conventional Device)
5.1.1 Cardiac Catheters
5.1.2 PTCA Balloons
5.1.3 Coronary Stents
5.1.4 Cardiac Valves
5.1.5 Others
5.2 Global Interventional Cardiology Market (by Advanced Device)
5.2.1 Intravascular Ultrasound (IVUS)
5.2.2 Fractional Flow Reserve (FFR)
5.2.3 Optical Coherence Tomography (OCT)

6 Global Interventional Cardiology Market (by End User)
6.1 Hospitals
6.2 Cardiac Catheterisation Laboratories
6.3 Ambulatory Surgical Centres
6.4 Others

7 Global Interventional Cardiology Market (by Region)

8 Company Profiles

ABIOMED, Inc.
ACIST Medical Systems, Inc.
B. Braun Melsungen AG
Biosense Webster, Inc
Biosensors International Group, Ltd.
Biotronik SE & Co. KG
Boston Scientific Corporation
C. R. Bard, Inc.
Cook Medical LLC
Cordis Corporation
Edwards Lifesciences Corporation
GE Healthcare
Koninklijke Philips N.V.
Life Vascular Devices Biotech S.L.
Medtronic Plc
Merit Medical Systems, Inc
Novacam Technologies Inc.
St. Jude Medical
Terumo Corporation
W. L. Gore & Associates, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/jmtx67/global?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets